British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of...
from NDTV News - Special https://ift.tt/3aCYrCE
via IFTTT
Post a Comment
Post a Comment